|
STREAMING VIDEO ARCHIVES
| ||||||
|
FOSEP HOME | |||||||
|
FOSEP's Library
Politicization of Science: A Perspective
Center for Science and Technology Policy Research
- Keeps a video archive of all guest speakers.
| |||||||
|
April 8, 2005 |
|
| |||||
|
April 7, 2005 |
Dealing with Scientific Uncertainty in Policymaking
Roger Pielke, Jr., Ph.D.
Uncertainty is ever present in decision making. But
even as scientists typically have sophisticated understandings of
uncertainty itself, such understandings are infrequently accompanied
by a corresponding sophistication in decision making in the face of
uncertainty. This talk will discuss a range of experiences in dealing
with scientific uncertainty in policymaking to suggest how the
scientific community might more effectively contribute useful guidance
on important policy issues characterized by fundamental uncertainties.
Dr. Pielke's talk will emphasize both the use of science in decision
making, but also decisions that are made about science, typically
under an expectation that the results of resulting research will
inform decision making. Consequently, issues of values, ethics and
politics are inescapable when one confronts scientific uncertainty in
policy making. |
VIDEO COMING SOON | |||||
|
|
|||||||
| February 4, 2005 |
Frankenfood or Fearmongering?
Executive Director,
Last year, American farmers grew more
genetically-modified (GM) crops
than ever before. About 75% of the processed foods in U.S. stores are
estimated to contain ingredients derived from GM crops.
Concerns have been
raised about food safety and environmental risks,
the
ethics of seed patenting,
Opinion pieces by Mr. Rodemeyer:
"Technology moves faster than regulators"
- USA Today 12/03
|
![]()
| |||||
|
|
|||||||
| October 18, 2004 |
Stem Cells:
|
||||||
|
Panelists Larry Goldstein, Jeffrey Kahn, and Anna Mastroianni address a packed house in University of Washington's Kane Hall on October 18th, 2004. |
|
|
EXPERT PANEL:
Science, therapies, and research challenges
Lawrence Goldstein, Ph.D. -
Professor of Cellular & Molecular Medicine, University of California, San
Diego; Investigator, Howard Hughes Medical Institute; Chair of Public
Policy, American Society for Cell Biology
Ethical considerations
Jeffrey Kahn, Ph.D., M.P.H. -
Director, Center of Bioethics, University of Minnesota
Stem cell policy: What are our options?
Anna Mastroianni, J.D., M.P.H.
- Assistant professor of Law and Public Health Genetics and
Greenwall Faculty Scholar on Bioethics, University of Washington.

Real Video (Compliments of the Seattle Channel)
May 14, 2004
Embryos and Cloning in Perspective:
The History of the Controversies
Regents' Professor
Director, Center
for Biology and Society
Arizona State University

Abstract:
When a new scientific advance
breaks through the news barrier and enters
public awareness, as cloning Dolly or culturing stem cell lines has
done, questions arise. We often hear a range of views from enthusiasm
to outrage. Careful reflection to assess what is really at issue and
what, for that matter, is really new is woefully rare. Surely, it
often seems, we are on the brink of a new cliff, about to plunge off
or to soar away to new heights. Yet history's lessons teach us that
momentary novelties often turn to routine and that the cliff really is
often just a bump in the road. In vitro fertilization, for example,
was hotly contested in the late 1970s but is now both a routine
treatment for infertility and a potential source of pre-implantation
embryos for research. To put our current debate in perspective, we
will look at the history of embryo research with a focus on cloning,
underlying epistemological assumptions, and bioethical discussions.
What regulations - if any - are needed to be sure that we don't plunge
off the cliff this time? In the end, Maienschein contends, we can
learn a lot from history.